Eczema Patients Have Lost Faith In Treatment: Survey
"); jQuery("#212 h3").html("

"); });
2022-09-13 HKT 20:53
A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.
GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.
Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.
He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.
“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.
“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.
“Public doctors have a limited time to see a lot of patients every day."
But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”
Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.
Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.
“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.
“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”
To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.
HKMA Warns Of Fake Stablecoins As Licensed Issuers Have Yet To Launch Tokens
The Hong Kong Monetary Authority (HKMA) has warned the public about fake stablecoins in Hong Kong, specifically flaggin... Read more
Tazapay Secures Money Service Operator License In Hong Kong
Singapore-based cross-border payments company Tazapay has secured a Money Service Operator (MSO) license in Hong Kong. ... Read more
Livi Bank Posts First Full-Year Profit In 2025 As Loans Rise 49%
Hong Kong digital bank livi bank reported a full-year profit of HK$21 million for 2025. For the year, total operating i... Read more
FWD Group Reports US$720M In New Business Sales As Expansion Continues
FWD Group reported a 4% year-on-year increase in new business sales to US$720 million for the first quarter of 2026, dr... Read more
WeLab Bank 2025 Revenue Hits HK$942M After Securing First-Half Profitability
WeLab Bank achieved profitability in the first half of 2025 and reported a 35% year-on-year revenue increase to HK$942 ... Read more
Ripple And Kbank Roll Out Institutional Digital Asset Wallet In South Korea
Ripple has partnered with Kbank to deploy an institutional digital asset wallet in Korea, equipping the internet bank w... Read more